semaglutide weight loss cascade Transforming obesity: The advancement of multi-receptor drugs: Cell Semaglutide: Double-edged Sword with Risks
Description
Restarting tirzepatide while breastfeeding is not typically recommended due to limited safety data in nursing individuals
What anesthesia guideline recommends treating patients who have taken GLP1 receptor agonists (e.g., tirzepatide, semaglutide, dulaglutide, exenatide, liraglutide) as having a full stomach, and where can this recommendation be found?
A lower maintenance dose is a middle path some providers consider, without controlled-trial evidence to guide it (Aronne et al., JAMA 2024)
Kennedy C, Hayes P, Salama S, Hennessy M, Fogacci F
ColonBroom vs Prescription GLP-1 Medications Prescription medications like semaglutide remain the benchmark for appetite control
I started at 267 pounds last January
